変異したミトコンドリアDNAポリメラーゼの活性を再生する小分子
Sebastian Valenzuela1, Xuefeng Zhu1, Bertil Macao1
1Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden.
Nature
|April 9, 2025
まとめ
科学者はミトコンドリア DNA (mtDNA) の合成を活性化する新しい小分子 PZL-A を発見した. この化合物は変異したDNAポリメラーゼガンマ (POLγ) の機能を回復させ,POLG障害とmtDNA枯渇疾患の治療に希望を与えます.
科学分野:
- 分子生物学
- 遺伝学
- 生物化学
背景:
- 哺乳類のミトコンドリアDNA (mtDNA) の複製は,触媒的なPOLγAと補助的なPOLγBサブユニットを持つ複合体であるDNAポリメラーゼガンマ (POLγ) に依存している.
- POLG遺伝子の300以上の変異が重篤なPOLG障害を引き起こし,現在の治療法なしでは高い罹病率と死亡率につながります.
研究 の 目的:
- mtDNA合成を活性化できる新しい小分子を発見し特徴づけること
- 変異したPOLγ変異体の機能を回復し,POLG関連疾患を治療するこの分子の可能性を調査する.
主な方法:
- mtDNA合成の小分子活性化剤であるPZL-Aの発見と特徴付け.
- 変異したPOLγの活性に対するPZL- Aの影響を評価する試験.
- 患者由来細胞を用いた細胞研究で,mtDNA合成と細胞呼吸に対するPZL-Aの影響を評価した.
主要な成果:
- PZL-Aは,ほとんどの病気を引き起こす変異によって影響を受けないPOLγのアロステリック部位に結合する.
- この化合物は,変異したPOLγに,野生型の活性を再生した.
- 致死性POLG疾患の患者の細胞でPZL- AがmtDNA合成を活性化し,酸化性リン酸化と細胞呼吸を強めた.
結論:
- 変異したDNAポリメラーゼの機能を 回復させることができるのです
- PZL-AはPOLG障害の治療戦略の第一弾です
- このアプローチは,mtDNAの枯渇に関連した様々な重症疾患の治療に有望です.
関連する概念動画
Translesion DNA Polymerases
9.9K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
9.9K
Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Proofreading
6.2K
Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore, it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase...
Errors During Replication are Corrected by the DNA Polymerase...
6.2K
Electron Transport Chain: Complex I and II
12.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.3K
DNA Topoisomerases
31.1K
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
31.1K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


